A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer

被引：0
|
作者：
Masahiro Tabata
Katsuyuki Kiura
Niro Okimoto
Yoshihiko Segawa
Tetsu Shinkai
Toshiro Yonei
Shoichi Kuyama
Shingo Harita
Katsuyuki Hotta
Hiroshi Ueoka
Mitsune Tanimoto
机构：
[1] Okayama University Medical School,Department of Medicine II
[2] Kawasaki Hospital,Department of Medicine
[3] National Hospital Organization Shikoku Cancer Center,Department of Medicine
[4] National Hospital Organization Okayama Medical Center,Department of Respiratory Medicine
[5] Chugoku Central Hospital,Department of Medicine
[6] National Hospital Organization National Sanyo Hospital,Department of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2007年 / 60卷
关键词：
Small-cell lung cancer; Alternating chemotherapy; Irinotecan;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1 / 6
页数：5
相关论文
共 50 条
  • [41] EFFICACY OF CYCLOPHOSPHAMIDE, EPIRUBICIN, AND ETOPOSIDE ALTERNATING WITH CISPLATIN AND ETOPOSIDE IN THE TREATMENT OF PATIENTS WITH SMALL-CELL LUNG-CANCER
    OZYILKAN, O
    KARS, A
    BALTALI, E
    TEKUZMAN, G
    OZYILKAN, E
    FIRAT, D
    JOURNAL OF CHEMOTHERAPY, 1993, 5 : 705 - 705
  • [42] Phase II study of irinotecan combined with carboplatin in previously untreated small-cell lung cancer
    A Kinoshita
    M Fukuda
    H Soda
    S Nagashima
    M Fukuda
    H Takatani
    M Kuba
    Y Nakamura
    J Tsurutani
    S Kohno
    M Oka
    British Journal of Cancer, 2006, 94 : 1267 - 1271
  • [43] Phase II study of irinotecan combined with carboplatin in previously untreated small-cell lung cancer
    Kinoshita, A
    Fukuda, M
    Soda, H
    Nagashima, S
    Fukuda, M
    Takatani, H
    Kuba, M
    Nakamura, Y
    Tsurutani, J
    Kohno, S
    Oka, M
    BRITISH JOURNAL OF CANCER, 2006, 94 (09) : 1267 - 1271
  • [44] Phase II study of a 3-week schedule of irinotecan combined with cisplatin in previously untreated extensive-stage small-cell lung cancer
    Lee, Jeong Eun
    Park, Hee Sun
    Jung, Sung Soo
    Kim, Ju Ock
    Kim, Sun Young
    ONCOLOGY, 2007, 73 (1-2) : 76 - 80
  • [45] A Phase II/III study comparing carboplatin and irinotecan with carboplatin and etoposide for the treatment of elderly patients with extensive-disease small-cell lung cancer (JCOG1201)
    Eba, Junko
    Shimokawa, Tsuneo
    Nakamura, Kenichi
    Shibata, Taro
    Misumi, Yuki
    Okamoto, Hiroaki
    Yamamoto, Noboru
    Ohe, Yuichiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (01) : 115 - 118
  • [46] Cisplatin Combined with Irinotecan or Etoposide for Untreated Extensive-Stage Small Cell Lung Cancer
    Shi, Yuankai
    Hu, Xingsheng
    Hu, Yi
    Han, Xiaohong
    Li, Xue
    Lin, Lin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S625 - S625
  • [47] CISPLATIN, DOXORUBICIN, CYCLOPHOSPHAMIDE, AND ETOPOSIDE COMBINATION CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER
    AISNER, J
    WHITACRE, MY
    BUDMAN, DR
    PROPERT, K
    STRAUSS, G
    VANECHO, DA
    PERRY, M
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 29 (06) : 435 - 438
  • [48] Randomized, phase III trial comparing irinotecan/cisplatin (IP) with etoposide/cisplatin (EP) in patients (pts) with previously untreated, extensive-stage (ES) small cell lung cancer (SCLC).
    Hanna, NH
    Einhorn, L
    Sandler, A
    Langer, C
    Hariharan, S
    Ansari, R
    Ellis, P
    Byrne, M
    Wang, B
    Bunn, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 1094S - 1094S
  • [49] Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancer
    K Goto
    I Sekine
    Y Nishiwaki
    R Kakinuma
    K Kubota
    T Matsumoto
    H Ohmatsu
    S Niho
    T Kodama
    T Shinkai
    T Tamura
    Y Ohe
    H Kunitoh
    N Yamamoto
    H Nokihara
    K Yoshida
    T Sugiura
    K Matsui
    N Saijo
    British Journal of Cancer, 2004, 91 : 659 - 665
  • [50] Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancer
    Goto, K
    Sekine, I
    Nishiwaki, Y
    Kakinuma, R
    Kubota, K
    Matsumoto, T
    Ohmatsu, H
    Niho, S
    Kodama, T
    Shinkai, T
    Tamura, T
    Ohe, Y
    Kunitoh, H
    Yamamoto, N
    Nokihara, H
    Yoshida, K
    Sugiura, T
    Matsui, K
    Saijo, N
    BRITISH JOURNAL OF CANCER, 2004, 91 (04) : 659 - 665
12345